VCM
ABBV icon

Voleon Capital Management’s AbbVie ABBV Stock Holding History

Voleon Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.7M Buy
164,004
+29,739
+22% +$6.6M 0.77% 18
2025
Q4 		$30.7M Buy
134,265
+26,707
+25% +$6.08M 0.66% 21
2025
Q3 		$24.9M Buy
107,558
+58,681
+120% +$11.9M 0.61% 24
2025
Q2 		$9.07M Sell
48,877
-12,157
-20% -$2.26M 0.5% 40
2025
Q1 		$12.8M Sell
61,034
-3,011
-5% -$585K 1% 17
2024
Q4 		$11.4M Buy
+64,045
New +$11.8M 0.85% 16
2019
Q3 		– Sell
-177,000
Closed -$12.9M – 149
2019
Q2 		$12.9M Buy
+177,000
New +$13.9M 0.74% 35

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Voleon Capital Management's ABBV Position: Q1 2026 in Review

Voleon Capital Management increased its AbbVie (ABBV) stake by 22% in Q1 2026, buying an estimated $6.6M and bringing the position to 164,004 shares worth $35.7M. The position accounts for 0.77% of the portfolio, ranked #18.

Voleon Capital Management first reported a position in ABBV in Q2 2019 and has held it in 7 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Voleon Capital Management held 164,004 shares of AbbVie worth $35.7M as of Q1 2026.
  • Voleon Capital Management bought 29,739 AbbVie shares in Q1 2026, an estimated $6.6M.
  • AbbVie made up 0.77% of Voleon Capital Management's portfolio in Q1 2026, its #18 holding.
  • Voleon Capital Management first reported a position in AbbVie in Q2 2019 and has held it in 7 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.